Overview

Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)

Status:
Completed
Trial end date:
2005-02-08
Target enrollment:
Participant gender:
Summary
Primary objective:To study the absolute bioavailability, distribution and elimination parameters of flucloxacillin from two oral formulations of flucloxacillin in healthy male and/or female subjects.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Floxacillin